Ontario Cancer Plan

Ontario Cancer Plan
Name	Ontario Cancer Plan
Formation	2005
Purpose	Cancer control planning and system coordination
Headquarters	Toronto
Region served	Ontario
Parent organization	Cancer Care Ontario

Ontario Cancer Plan The Ontario Cancer Plan is a provincially focused strategic framework for cancer prevention, diagnosis, treatment, and survivorship coordination in Ontario. The Plan aligns provincial health delivery with provincial policy instruments and inter-institutional actors across Toronto, Hamilton, Ontario, Ottawa, London, Ontario, and other regional centres. It integrates service delivery models used by institutions such as Princess Margaret Cancer Centre, Sunnybrook Health Sciences Centre, Juravinski Cancer Centre, Ottawa Hospital Cancer Centre, and provincial agencies including Cancer Care Ontario and the Ontario Ministry of Health and Long-Term Care.

Overview

The Plan establishes system-level priorities influenced by national and international frameworks including Canadian Partnership Against Cancer, World Health Organization, Pan American Health Organization, International Agency for Research on Cancer, and links with academic partners such as University of Toronto, McMaster University, Queen's University, Western University, and McGill University. It addresses screening programs tied to Ontario Breast Screening Program, ColonCancerCheck, and smoking cessation initiatives connected to Smoke-Free Ontario Act. The Plan coordinates with hospitals like St. Michael's Hospital (Toronto), Princess Margaret Cancer Centre, and regional networks such as Local Health Integration Network entities to streamline pathways for patients referred from primary care providers affiliated with Family Health Teams and services in rural areas like Thunder Bay and Sudbury, Ontario.

History and Development

Initial iterations followed models of cancer control planning exemplified by plans from National Health Service agencies and initiatives such as the Canadian Strategy for Cancer Control. Early development involved stakeholders including the Ontario Medical Association, oncology programs at The Hospital for Sick Children, and advocacy groups like Canadian Cancer Society. Pilots drew on evidence from clinical trials overseen by cooperative groups such as the Canadian Cancer Trials Group and implementation science from centres including Institute for Clinical Evaluative Sciences and Ontario Health Technology Advisory Committee. The Plan evolved through successive versions responding to demographic trends from Statistics Canada and legislative contexts including amendments related to the Cancer Act in other jurisdictions.

Objectives and Strategic Priorities

Primary objectives target reduced incidence and improved survival for malignancies such as breast cancer, colorectal cancer, lung cancer, prostate cancer, and hematologic malignancies like leukemia and lymphoma. Strategic priorities emphasize timely access to multidisciplinary care shown in models at Princess Margaret Cancer Centre, integration of precision medicine approaches informed by initiatives at Broad Institute collaborators, and expansion of palliative services exemplified by programs at Holland Bloorview Kids Rehabilitation Hospital and hospice networks. Priorities include workforce planning referencing professional bodies such as the Royal College of Physicians and Surgeons of Canada, cancer nursing standards from the Canadian Nurses Association, and data-driven decision-making from agencies like ICES.

Implementation and Programs

Implementation spans population screening programs like ColonCancerCheck and targeted vaccination initiatives linked to the Human papillomavirus vaccine rollout overseen in collaboration with public health units like Toronto Public Health and Ottawa Public Health. Treatment delivery reforms incorporate evidence from randomized controlled trials presented at conferences such as the American Society of Clinical Oncology and European Society for Medical Oncology. Programmatic elements include multidisciplinary tumour boards modeled after practices at Princess Margaret Cancer Centre and integration of diagnostic imaging networks using standards from Radiological Society of North America and Canadian Association of Radiologists. Survivorship programs coordinate with rehabilitation services at institutions like Sunnybrook Health Sciences Centre.

Governance and Funding

Governance structures involve provincial oversight bodies including Cancer Care Ontario (now integrated into Ontario Health), provincial ministries such as the Ontario Ministry of Health and Long-Term Care, and advisory input from academic hospitals including Mount Sinai Hospital (Toronto) and Hamilton Health Sciences. Funding streams combine provincial budget allocations, research grants from bodies like the Canadian Institutes of Health Research, philanthropic contributions from organizations such as the Princess Margaret Cancer Foundation, and partnerships with industry stakeholders including global pharmaceutical firms represented at meetings like the BIO International Convention.

Monitoring, Evaluation, and Outcomes

Monitoring relies on provincial registries such as the Ontario Cancer Registry and analytic capacity from Institute for Clinical Evaluative Sciences to track outcomes including stage at diagnosis, five-year survival, and wait times benchmarked against standards used by Cancer Care Ontario and metrics comparable to results published by Statistics Canada and the Canadian Institute for Health Information. Evaluation employs performance frameworks akin to those used by the National Health Service, peer-reviewed evidence disseminated via journals like The Lancet Oncology, and health economic analyses referencing methods from Canadian Agency for Drugs and Technologies in Health.

Criticisms and Challenges

Critiques have focused on disparities in access between urban centres such as Toronto and rural communities including Timmins, Ontario and Kenora District, resource constraints highlighted by debates involving the Ontario Medical Association, and tension between centralized planning and local autonomy as seen in discussions at Local Health Integration Network meetings. Additional challenges include implementation of precision oncology constrained by regulatory processes overseen by Health Canada, data governance concerns raised by privacy statutes such as the Personal Health Information Protection Act, 2004, and balancing cost-effectiveness considerations advocated by the Canadian Institute for Health Research and health technology assessment agencies.

Category:Health in Ontario